
================================================================================
Q: Compare and contrast roles of TP53 and BRCA1 in cancer biology
[gene_extraction_node] extracted: ['TP53', 'BRCA1']
[has_genes] genes present? True
[TOOL SELECTION] Claude (Haiku) selected: ['uniprot_base', 'gwas', 'uniprot_gwas', 'BioGRID', 'Summarize_bioGRID_GO']
[TOOL RUN] → uniprot_base
Fetching UniProt entry for gene: TP53
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck', 'function': 'Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2', 'go_terms': "C:PML body, C:centrosome, C:chromatin, C:cytoplasm, C:cytosol, C:endoplasmic reticulum, C:germ cell nucleus, C:mitochondrial matrix, C:mitochondrion, C:nuclear matrix, C:nucleolus, C:nucleoplasm, C:nucleus, C:protein-containing complex, C:replication fork, C:site of double-strand break, C:transcription regulator complex, C:transcription repressor complex, F:14-3-3 protein binding, F:ATP-dependent DNA/DNA annealing activity, F:DNA binding, F:DNA-binding transcription activator activity, RNA polymerase II-specific, F:DNA-binding transcription factor activity, F:DNA-binding transcription factor activity, RNA polymerase II-specific, F:DNA-binding transcription repressor activity, RNA polymerase II-specific, F:MDM2/MDM4 family protein binding, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, F:RNA polymerase II-specific DNA-binding transcription factor binding, F:TFIID-class transcription factor complex binding, F:chromatin binding, F:cis-regulatory region sequence-specific DNA binding, F:copper ion binding, F:core promoter sequence-specific DNA binding, F:disordered domain specific binding, F:enzyme binding, F:general transcription initiation factor binding, F:histone deacetylase binding, F:histone deacetylase regulator activity, F:identical protein binding, F:mRNA 3'-UTR binding, F:molecular condensate scaffold activity, F:molecular function activator activity, F:p53 binding, F:promoter-specific chromatin binding, F:protease binding, F:protein heterodimerization activity, F:protein phosphatase 2A binding, F:protein-folding chaperone binding, F:receptor tyrosine kinase binding, F:transcription cis-regulatory region binding, F:transcription coactivator binding, F:ubiquitin protein ligase binding, F:zinc ion binding, P:B cell lineage commitment, P:DNA damage response, P:DNA damage response, signal transduction by p53 class mediator, P:ER overload response, P:Ras protein signal transduction, P:T cell differentiation in thymus, P:T cell lineage commitment, P:T cell proliferation involved in immune response, P:autophagy, P:bone marrow development, P:cardiac muscle cell apoptotic process, P:cardiac septum morphogenesis, P:cellular response to UV, P:cellular response to UV-C, P:cellular response to actinomycin D, P:cellular response to gamma radiation, P:cellular response to glucose starvation, P:cellular response to hypoxia, P:cellular response to ionizing radiation, P:cellular response to xenobiotic stimulus, P:cellular senescence, P:cerebellum development, P:chromosome organization, P:circadian behavior, P:determination of adult lifespan, P:double-strand break repair, P:embryonic organ development, P:entrainment of circadian clock by photoperiod, P:fibroblast proliferation, P:gastrulation, P:glial cell proliferation, P:glucose catabolic process to lactate via pyruvate, P:hematopoietic progenitor cell differentiation, P:hematopoietic stem cell differentiation, P:in utero embryonic development, P:intrinsic apoptotic signaling pathway, P:intrinsic apoptotic signaling pathway by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, P:intrinsic apoptotic signaling pathway in response to hypoxia, P:mRNA transcription, P:mitochondrial DNA repair, P:mitophagy, P:mitotic G1 DNA damage checkpoint signaling, P:multicellular organism growth, P:necroptotic process, P:negative regulation of DNA replication, P:negative regulation of DNA-templated transcription, P:negative regulation of G1 to G0 transition, P:negative regulation of apoptotic process, P:negative regulation of cell growth, P:negative regulation of cell population proliferation, P:negative regulation of fibroblast proliferation, P:negative regulation of glial cell proliferation, P:negative regulation of glucose catabolic process to lactate via pyruvate, P:negative regulation of helicase activity, P:negative regulation of miRNA processing, P:negative regulation of mitophagy, P:negative regulation of neuroblast proliferation, P:negative regulation of pentose-phosphate shunt, P:negative regulation of proteolysis, P:negative regulation of reactive oxygen species metabolic process, P:negative regulation of stem cell proliferation, P:negative regulation of telomere maintenance via telomerase, P:negative regulation of transcription by RNA polymerase II, P:negative regulation of transforming growth factor beta receptor signaling pathway, P:neuroblast proliferation, P:neuron apoptotic process, P:nucleotide-excision repair, P:oligodendrocyte apoptotic process, P:oxidative stress-induced premature senescence, P:positive regulation of DNA-templated transcription, P:positive regulation of RNA polymerase II transcription preinitiation complex assembly, P:positive regulation of apoptotic process, P:positive regulation of cardiac muscle cell apoptotic process, P:positive regulation of cellular senescence, P:positive regulation of execution phase of apoptosis, P:positive regulation of gene expression, P:positive regulation of intrinsic apoptotic signaling pathway, P:positive regulation of miRNA transcription, P:positive regulation of mitochondrial membrane permeability, P:positive regulation of neuron apoptotic process, P:positive regulation of programmed necrotic cell death, P:positive regulation of reactive oxygen species metabolic process, P:positive regulation of release of cytochrome c from mitochondria, P:positive regulation of thymocyte apoptotic process, P:positive regulation of transcription by RNA polymerase II, P:protein import into nucleus, P:protein localization, P:protein stabilization, P:protein tetramerization, P:protein-containing complex assembly, P:rRNA transcription, P:reactive oxygen species metabolic process, P:regulation of DNA damage response, signal transduction by p53 class mediator, P:regulation of DNA-templated transcription, P:regulation of apoptotic process, P:regulation of cell cycle, P:regulation of cell cycle G2/M phase transition, P:regulation of fibroblast apoptotic process, P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator, P:regulation of mitochondrial membrane permeability involved in apoptotic process, P:regulation of tissue remodeling, P:regulation of transcription by RNA polymerase II, P:release of cytochrome c from mitochondria, P:replicative senescence, P:response to X-ray, P:response to antibiotic, P:response to gamma radiation, P:response to ischemia, P:response to salt stress, P:signal transduction by p53 class mediator, P:somitogenesis, P:stem cell proliferation, P:thymocyte apoptotic process, P:transcription initiation-coupled chromatin remodeling, P:transforming growth factor beta receptor signaling pathway, P:tumor necrosis factor-mediated signaling pathway, P:type II interferon-mediated signaling pathway, P:viral process"}
Fetching UniProt entry for gene: TP53
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck', 'function': 'Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2', 'go_terms': "C:PML body, C:centrosome, C:chromatin, C:cytoplasm, C:cytosol, C:endoplasmic reticulum, C:germ cell nucleus, C:mitochondrial matrix, C:mitochondrion, C:nuclear matrix, C:nucleolus, C:nucleoplasm, C:nucleus, C:protein-containing complex, C:replication fork, C:site of double-strand break, C:transcription regulator complex, C:transcription repressor complex, F:14-3-3 protein binding, F:ATP-dependent DNA/DNA annealing activity, F:DNA binding, F:DNA-binding transcription activator activity, RNA polymerase II-specific, F:DNA-binding transcription factor activity, F:DNA-binding transcription factor activity, RNA polymerase II-specific, F:DNA-binding transcription repressor activity, RNA polymerase II-specific, F:MDM2/MDM4 family protein binding, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, F:RNA polymerase II-specific DNA-binding transcription factor binding, F:TFIID-class transcription factor complex binding, F:chromatin binding, F:cis-regulatory region sequence-specific DNA binding, F:copper ion binding, F:core promoter sequence-specific DNA binding, F:disordered domain specific binding, F:enzyme binding, F:general transcription initiation factor binding, F:histone deacetylase binding, F:histone deacetylase regulator activity, F:identical protein binding, F:mRNA 3'-UTR binding, F:molecular condensate scaffold activity, F:molecular function activator activity, F:p53 binding, F:promoter-specific chromatin binding, F:protease binding, F:protein heterodimerization activity, F:protein phosphatase 2A binding, F:protein-folding chaperone binding, F:receptor tyrosine kinase binding, F:transcription cis-regulatory region binding, F:transcription coactivator binding, F:ubiquitin protein ligase binding, F:zinc ion binding, P:B cell lineage commitment, P:DNA damage response, P:DNA damage response, signal transduction by p53 class mediator, P:ER overload response, P:Ras protein signal transduction, P:T cell differentiation in thymus, P:T cell lineage commitment, P:T cell proliferation involved in immune response, P:autophagy, P:bone marrow development, P:cardiac muscle cell apoptotic process, P:cardiac septum morphogenesis, P:cellular response to UV, P:cellular response to UV-C, P:cellular response to actinomycin D, P:cellular response to gamma radiation, P:cellular response to glucose starvation, P:cellular response to hypoxia, P:cellular response to ionizing radiation, P:cellular response to xenobiotic stimulus, P:cellular senescence, P:cerebellum development, P:chromosome organization, P:circadian behavior, P:determination of adult lifespan, P:double-strand break repair, P:embryonic organ development, P:entrainment of circadian clock by photoperiod, P:fibroblast proliferation, P:gastrulation, P:glial cell proliferation, P:glucose catabolic process to lactate via pyruvate, P:hematopoietic progenitor cell differentiation, P:hematopoietic stem cell differentiation, P:in utero embryonic development, P:intrinsic apoptotic signaling pathway, P:intrinsic apoptotic signaling pathway by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, P:intrinsic apoptotic signaling pathway in response to hypoxia, P:mRNA transcription, P:mitochondrial DNA repair, P:mitophagy, P:mitotic G1 DNA damage checkpoint signaling, P:multicellular organism growth, P:necroptotic process, P:negative regulation of DNA replication, P:negative regulation of DNA-templated transcription, P:negative regulation of G1 to G0 transition, P:negative regulation of apoptotic process, P:negative regulation of cell growth, P:negative regulation of cell population proliferation, P:negative regulation of fibroblast proliferation, P:negative regulation of glial cell proliferation, P:negative regulation of glucose catabolic process to lactate via pyruvate, P:negative regulation of helicase activity, P:negative regulation of miRNA processing, P:negative regulation of mitophagy, P:negative regulation of neuroblast proliferation, P:negative regulation of pentose-phosphate shunt, P:negative regulation of proteolysis, P:negative regulation of reactive oxygen species metabolic process, P:negative regulation of stem cell proliferation, P:negative regulation of telomere maintenance via telomerase, P:negative regulation of transcription by RNA polymerase II, P:negative regulation of transforming growth factor beta receptor signaling pathway, P:neuroblast proliferation, P:neuron apoptotic process, P:nucleotide-excision repair, P:oligodendrocyte apoptotic process, P:oxidative stress-induced premature senescence, P:positive regulation of DNA-templated transcription, P:positive regulation of RNA polymerase II transcription preinitiation complex assembly, P:positive regulation of apoptotic process, P:positive regulation of cardiac muscle cell apoptotic process, P:positive regulation of cellular senescence, P:positive regulation of execution phase of apoptosis, P:positive regulation of gene expression, P:positive regulation of intrinsic apoptotic signaling pathway, P:positive regulation of miRNA transcription, P:positive regulation of mitochondrial membrane permeability, P:positive regulation of neuron apoptotic process, P:positive regulation of programmed necrotic cell death, P:positive regulation of reactive oxygen species metabolic process, P:positive regulation of release of cytochrome c from mitochondria, P:positive regulation of thymocyte apoptotic process, P:positive regulation of transcription by RNA polymerase II, P:protein import into nucleus, P:protein localization, P:protein stabilization, P:protein tetramerization, P:protein-containing complex assembly, P:rRNA transcription, P:reactive oxygen species metabolic process, P:regulation of DNA damage response, signal transduction by p53 class mediator, P:regulation of DNA-templated transcription, P:regulation of apoptotic process, P:regulation of cell cycle, P:regulation of cell cycle G2/M phase transition, P:regulation of fibroblast apoptotic process, P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator, P:regulation of mitochondrial membrane permeability involved in apoptotic process, P:regulation of tissue remodeling, P:regulation of transcription by RNA polymerase II, P:release of cytochrome c from mitochondria, P:replicative senescence, P:response to X-ray, P:response to antibiotic, P:response to gamma radiation, P:response to ischemia, P:response to salt stress, P:signal transduction by p53 class mediator, P:somitogenesis, P:stem cell proliferation, P:thymocyte apoptotic process, P:transcription initiation-coupled chromatin remodeling, P:transforming growth factor beta receptor signaling pathway, P:tumor necrosis factor-mediated signaling pathway, P:type II interferon-mediated signaling pathway, P:viral process"}
Fetching UniProt entry for gene: BRCA1
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4', 'function': "E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator", 'go_terms': 'C:BRCA1-A complex, C:BRCA1-B complex, C:BRCA1-BARD1 complex, C:BRCA1-C complex, C:DNA repair complex, C:XY body, C:chromosome, C:cytoplasm, C:gamma-tubulin ring complex, C:intracellular membraneless organelle, C:lateral element, C:male germ cell nucleus, C:nuclear body, C:nuclear ubiquitin ligase complex, C:nucleoplasm, C:nucleus, C:plasma membrane, C:protein-containing complex, C:ribonucleoprotein complex, C:ubiquitin ligase complex, F:DNA binding, F:RNA binding, F:RNA polymerase binding, F:damaged DNA binding, F:enzyme binding, F:histone H2AK127 ubiquitin ligase activity, F:histone H2AK129 ubiquitin ligase activity, F:identical protein binding, F:p53 binding, F:transcription cis-regulatory region binding, F:transcription coactivator activity, F:tubulin binding, F:ubiquitin protein ligase binding, F:ubiquitin-modified histone reader activity, F:ubiquitin-protein transferase activity, F:zinc ion binding, P:DNA damage response, P:DNA repair, P:DNA strand resection involved in replication fork processing, P:cellular response to indole-3-methanol, P:cellular response to ionizing radiation, P:cellular response to tumor necrosis factor, P:centrosome cycle, P:chordate embryonic development, P:chromatin remodeling, P:chromosome segregation, P:double-strand break repair, P:double-strand break repair via homologous recombination, P:fatty acid biosynthetic process, P:homologous recombination, P:intrinsic apoptotic signaling pathway in response to DNA damage, P:mitotic G2 DNA damage checkpoint signaling, P:mitotic G2/M transition checkpoint, P:negative regulation of DNA-templated transcription, P:negative regulation of cell cycle, P:negative regulation of cell growth, P:negative regulation of centriole replication, P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, P:negative regulation of fatty acid biosynthetic process, P:negative regulation of gene expression via chromosomal CpG island methylation, P:negative regulation of intracellular estrogen receptor signaling pathway, P:negative regulation of reactive oxygen species metabolic process, P:positive regulation of DNA repair, P:positive regulation of DNA-templated transcription, P:positive regulation of angiogenesis, P:positive regulation of gene expression, P:positive regulation of transcription by RNA polymerase II, P:positive regulation of vascular endothelial growth factor production, P:postreplication repair, P:protein K6-linked ubiquitination, P:protein autoubiquitination, P:protein ubiquitination, P:random inactivation of X chromosome, P:regulation of DNA damage checkpoint, P:regulation of DNA repair, P:regulation of cell cycle, P:regulation of transcription by RNA polymerase II, P:response to ionizing radiation, P:sex-chromosome dosage compensation'}
Fetching UniProt entry for gene: BRCA1
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4', 'function': "E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator", 'go_terms': 'C:BRCA1-A complex, C:BRCA1-B complex, C:BRCA1-BARD1 complex, C:BRCA1-C complex, C:DNA repair complex, C:XY body, C:chromosome, C:cytoplasm, C:gamma-tubulin ring complex, C:intracellular membraneless organelle, C:lateral element, C:male germ cell nucleus, C:nuclear body, C:nuclear ubiquitin ligase complex, C:nucleoplasm, C:nucleus, C:plasma membrane, C:protein-containing complex, C:ribonucleoprotein complex, C:ubiquitin ligase complex, F:DNA binding, F:RNA binding, F:RNA polymerase binding, F:damaged DNA binding, F:enzyme binding, F:histone H2AK127 ubiquitin ligase activity, F:histone H2AK129 ubiquitin ligase activity, F:identical protein binding, F:p53 binding, F:transcription cis-regulatory region binding, F:transcription coactivator activity, F:tubulin binding, F:ubiquitin protein ligase binding, F:ubiquitin-modified histone reader activity, F:ubiquitin-protein transferase activity, F:zinc ion binding, P:DNA damage response, P:DNA repair, P:DNA strand resection involved in replication fork processing, P:cellular response to indole-3-methanol, P:cellular response to ionizing radiation, P:cellular response to tumor necrosis factor, P:centrosome cycle, P:chordate embryonic development, P:chromatin remodeling, P:chromosome segregation, P:double-strand break repair, P:double-strand break repair via homologous recombination, P:fatty acid biosynthetic process, P:homologous recombination, P:intrinsic apoptotic signaling pathway in response to DNA damage, P:mitotic G2 DNA damage checkpoint signaling, P:mitotic G2/M transition checkpoint, P:negative regulation of DNA-templated transcription, P:negative regulation of cell cycle, P:negative regulation of cell growth, P:negative regulation of centriole replication, P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, P:negative regulation of fatty acid biosynthetic process, P:negative regulation of gene expression via chromosomal CpG island methylation, P:negative regulation of intracellular estrogen receptor signaling pathway, P:negative regulation of reactive oxygen species metabolic process, P:positive regulation of DNA repair, P:positive regulation of DNA-templated transcription, P:positive regulation of angiogenesis, P:positive regulation of gene expression, P:positive regulation of transcription by RNA polymerase II, P:positive regulation of vascular endothelial growth factor production, P:postreplication repair, P:protein K6-linked ubiquitination, P:protein autoubiquitination, P:protein ubiquitination, P:random inactivation of X chromosome, P:regulation of DNA damage checkpoint, P:regulation of DNA repair, P:regulation of cell cycle, P:regulation of transcription by RNA polymerase II, P:response to ionizing radiation, P:sex-chromosome dosage compensation'}
[TOOL RUN] → gwas
[GWAS] Querying associations for gene: TP53
[GWAS] TP53: found, 653 total associations, 603 significant, 131 studies
[GWAS] Querying associations for gene: BRCA1
[GWAS] BRCA1: found, 26 total associations, 24 significant, 18 studies
[TOOL RUN] → uniprot_gwas
Fetching UniProt entry for gene: TP53
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck', 'function': 'Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2', 'go_terms': "C:PML body, C:centrosome, C:chromatin, C:cytoplasm, C:cytosol, C:endoplasmic reticulum, C:germ cell nucleus, C:mitochondrial matrix, C:mitochondrion, C:nuclear matrix, C:nucleolus, C:nucleoplasm, C:nucleus, C:protein-containing complex, C:replication fork, C:site of double-strand break, C:transcription regulator complex, C:transcription repressor complex, F:14-3-3 protein binding, F:ATP-dependent DNA/DNA annealing activity, F:DNA binding, F:DNA-binding transcription activator activity, RNA polymerase II-specific, F:DNA-binding transcription factor activity, F:DNA-binding transcription factor activity, RNA polymerase II-specific, F:DNA-binding transcription repressor activity, RNA polymerase II-specific, F:MDM2/MDM4 family protein binding, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, F:RNA polymerase II-specific DNA-binding transcription factor binding, F:TFIID-class transcription factor complex binding, F:chromatin binding, F:cis-regulatory region sequence-specific DNA binding, F:copper ion binding, F:core promoter sequence-specific DNA binding, F:disordered domain specific binding, F:enzyme binding, F:general transcription initiation factor binding, F:histone deacetylase binding, F:histone deacetylase regulator activity, F:identical protein binding, F:mRNA 3'-UTR binding, F:molecular condensate scaffold activity, F:molecular function activator activity, F:p53 binding, F:promoter-specific chromatin binding, F:protease binding, F:protein heterodimerization activity, F:protein phosphatase 2A binding, F:protein-folding chaperone binding, F:receptor tyrosine kinase binding, F:transcription cis-regulatory region binding, F:transcription coactivator binding, F:ubiquitin protein ligase binding, F:zinc ion binding, P:B cell lineage commitment, P:DNA damage response, P:DNA damage response, signal transduction by p53 class mediator, P:ER overload response, P:Ras protein signal transduction, P:T cell differentiation in thymus, P:T cell lineage commitment, P:T cell proliferation involved in immune response, P:autophagy, P:bone marrow development, P:cardiac muscle cell apoptotic process, P:cardiac septum morphogenesis, P:cellular response to UV, P:cellular response to UV-C, P:cellular response to actinomycin D, P:cellular response to gamma radiation, P:cellular response to glucose starvation, P:cellular response to hypoxia, P:cellular response to ionizing radiation, P:cellular response to xenobiotic stimulus, P:cellular senescence, P:cerebellum development, P:chromosome organization, P:circadian behavior, P:determination of adult lifespan, P:double-strand break repair, P:embryonic organ development, P:entrainment of circadian clock by photoperiod, P:fibroblast proliferation, P:gastrulation, P:glial cell proliferation, P:glucose catabolic process to lactate via pyruvate, P:hematopoietic progenitor cell differentiation, P:hematopoietic stem cell differentiation, P:in utero embryonic development, P:intrinsic apoptotic signaling pathway, P:intrinsic apoptotic signaling pathway by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, P:intrinsic apoptotic signaling pathway in response to hypoxia, P:mRNA transcription, P:mitochondrial DNA repair, P:mitophagy, P:mitotic G1 DNA damage checkpoint signaling, P:multicellular organism growth, P:necroptotic process, P:negative regulation of DNA replication, P:negative regulation of DNA-templated transcription, P:negative regulation of G1 to G0 transition, P:negative regulation of apoptotic process, P:negative regulation of cell growth, P:negative regulation of cell population proliferation, P:negative regulation of fibroblast proliferation, P:negative regulation of glial cell proliferation, P:negative regulation of glucose catabolic process to lactate via pyruvate, P:negative regulation of helicase activity, P:negative regulation of miRNA processing, P:negative regulation of mitophagy, P:negative regulation of neuroblast proliferation, P:negative regulation of pentose-phosphate shunt, P:negative regulation of proteolysis, P:negative regulation of reactive oxygen species metabolic process, P:negative regulation of stem cell proliferation, P:negative regulation of telomere maintenance via telomerase, P:negative regulation of transcription by RNA polymerase II, P:negative regulation of transforming growth factor beta receptor signaling pathway, P:neuroblast proliferation, P:neuron apoptotic process, P:nucleotide-excision repair, P:oligodendrocyte apoptotic process, P:oxidative stress-induced premature senescence, P:positive regulation of DNA-templated transcription, P:positive regulation of RNA polymerase II transcription preinitiation complex assembly, P:positive regulation of apoptotic process, P:positive regulation of cardiac muscle cell apoptotic process, P:positive regulation of cellular senescence, P:positive regulation of execution phase of apoptosis, P:positive regulation of gene expression, P:positive regulation of intrinsic apoptotic signaling pathway, P:positive regulation of miRNA transcription, P:positive regulation of mitochondrial membrane permeability, P:positive regulation of neuron apoptotic process, P:positive regulation of programmed necrotic cell death, P:positive regulation of reactive oxygen species metabolic process, P:positive regulation of release of cytochrome c from mitochondria, P:positive regulation of thymocyte apoptotic process, P:positive regulation of transcription by RNA polymerase II, P:protein import into nucleus, P:protein localization, P:protein stabilization, P:protein tetramerization, P:protein-containing complex assembly, P:rRNA transcription, P:reactive oxygen species metabolic process, P:regulation of DNA damage response, signal transduction by p53 class mediator, P:regulation of DNA-templated transcription, P:regulation of apoptotic process, P:regulation of cell cycle, P:regulation of cell cycle G2/M phase transition, P:regulation of fibroblast apoptotic process, P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator, P:regulation of mitochondrial membrane permeability involved in apoptotic process, P:regulation of tissue remodeling, P:regulation of transcription by RNA polymerase II, P:release of cytochrome c from mitochondria, P:replicative senescence, P:response to X-ray, P:response to antibiotic, P:response to gamma radiation, P:response to ischemia, P:response to salt stress, P:signal transduction by p53 class mediator, P:somitogenesis, P:stem cell proliferation, P:thymocyte apoptotic process, P:transcription initiation-coupled chromatin remodeling, P:transforming growth factor beta receptor signaling pathway, P:tumor necrosis factor-mediated signaling pathway, P:type II interferon-mediated signaling pathway, P:viral process"}
Fetching UniProt entry for gene: TP53
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck', 'function': 'Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2', 'go_terms': "C:PML body, C:centrosome, C:chromatin, C:cytoplasm, C:cytosol, C:endoplasmic reticulum, C:germ cell nucleus, C:mitochondrial matrix, C:mitochondrion, C:nuclear matrix, C:nucleolus, C:nucleoplasm, C:nucleus, C:protein-containing complex, C:replication fork, C:site of double-strand break, C:transcription regulator complex, C:transcription repressor complex, F:14-3-3 protein binding, F:ATP-dependent DNA/DNA annealing activity, F:DNA binding, F:DNA-binding transcription activator activity, RNA polymerase II-specific, F:DNA-binding transcription factor activity, F:DNA-binding transcription factor activity, RNA polymerase II-specific, F:DNA-binding transcription repressor activity, RNA polymerase II-specific, F:MDM2/MDM4 family protein binding, F:RNA polymerase II cis-regulatory region sequence-specific DNA binding, F:RNA polymerase II-specific DNA-binding transcription factor binding, F:TFIID-class transcription factor complex binding, F:chromatin binding, F:cis-regulatory region sequence-specific DNA binding, F:copper ion binding, F:core promoter sequence-specific DNA binding, F:disordered domain specific binding, F:enzyme binding, F:general transcription initiation factor binding, F:histone deacetylase binding, F:histone deacetylase regulator activity, F:identical protein binding, F:mRNA 3'-UTR binding, F:molecular condensate scaffold activity, F:molecular function activator activity, F:p53 binding, F:promoter-specific chromatin binding, F:protease binding, F:protein heterodimerization activity, F:protein phosphatase 2A binding, F:protein-folding chaperone binding, F:receptor tyrosine kinase binding, F:transcription cis-regulatory region binding, F:transcription coactivator binding, F:ubiquitin protein ligase binding, F:zinc ion binding, P:B cell lineage commitment, P:DNA damage response, P:DNA damage response, signal transduction by p53 class mediator, P:ER overload response, P:Ras protein signal transduction, P:T cell differentiation in thymus, P:T cell lineage commitment, P:T cell proliferation involved in immune response, P:autophagy, P:bone marrow development, P:cardiac muscle cell apoptotic process, P:cardiac septum morphogenesis, P:cellular response to UV, P:cellular response to UV-C, P:cellular response to actinomycin D, P:cellular response to gamma radiation, P:cellular response to glucose starvation, P:cellular response to hypoxia, P:cellular response to ionizing radiation, P:cellular response to xenobiotic stimulus, P:cellular senescence, P:cerebellum development, P:chromosome organization, P:circadian behavior, P:determination of adult lifespan, P:double-strand break repair, P:embryonic organ development, P:entrainment of circadian clock by photoperiod, P:fibroblast proliferation, P:gastrulation, P:glial cell proliferation, P:glucose catabolic process to lactate via pyruvate, P:hematopoietic progenitor cell differentiation, P:hematopoietic stem cell differentiation, P:in utero embryonic development, P:intrinsic apoptotic signaling pathway, P:intrinsic apoptotic signaling pathway by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, P:intrinsic apoptotic signaling pathway in response to hypoxia, P:mRNA transcription, P:mitochondrial DNA repair, P:mitophagy, P:mitotic G1 DNA damage checkpoint signaling, P:multicellular organism growth, P:necroptotic process, P:negative regulation of DNA replication, P:negative regulation of DNA-templated transcription, P:negative regulation of G1 to G0 transition, P:negative regulation of apoptotic process, P:negative regulation of cell growth, P:negative regulation of cell population proliferation, P:negative regulation of fibroblast proliferation, P:negative regulation of glial cell proliferation, P:negative regulation of glucose catabolic process to lactate via pyruvate, P:negative regulation of helicase activity, P:negative regulation of miRNA processing, P:negative regulation of mitophagy, P:negative regulation of neuroblast proliferation, P:negative regulation of pentose-phosphate shunt, P:negative regulation of proteolysis, P:negative regulation of reactive oxygen species metabolic process, P:negative regulation of stem cell proliferation, P:negative regulation of telomere maintenance via telomerase, P:negative regulation of transcription by RNA polymerase II, P:negative regulation of transforming growth factor beta receptor signaling pathway, P:neuroblast proliferation, P:neuron apoptotic process, P:nucleotide-excision repair, P:oligodendrocyte apoptotic process, P:oxidative stress-induced premature senescence, P:positive regulation of DNA-templated transcription, P:positive regulation of RNA polymerase II transcription preinitiation complex assembly, P:positive regulation of apoptotic process, P:positive regulation of cardiac muscle cell apoptotic process, P:positive regulation of cellular senescence, P:positive regulation of execution phase of apoptosis, P:positive regulation of gene expression, P:positive regulation of intrinsic apoptotic signaling pathway, P:positive regulation of miRNA transcription, P:positive regulation of mitochondrial membrane permeability, P:positive regulation of neuron apoptotic process, P:positive regulation of programmed necrotic cell death, P:positive regulation of reactive oxygen species metabolic process, P:positive regulation of release of cytochrome c from mitochondria, P:positive regulation of thymocyte apoptotic process, P:positive regulation of transcription by RNA polymerase II, P:protein import into nucleus, P:protein localization, P:protein stabilization, P:protein tetramerization, P:protein-containing complex assembly, P:rRNA transcription, P:reactive oxygen species metabolic process, P:regulation of DNA damage response, signal transduction by p53 class mediator, P:regulation of DNA-templated transcription, P:regulation of apoptotic process, P:regulation of cell cycle, P:regulation of cell cycle G2/M phase transition, P:regulation of fibroblast apoptotic process, P:regulation of intrinsic apoptotic signaling pathway by p53 class mediator, P:regulation of mitochondrial membrane permeability involved in apoptotic process, P:regulation of tissue remodeling, P:regulation of transcription by RNA polymerase II, P:release of cytochrome c from mitochondria, P:replicative senescence, P:response to X-ray, P:response to antibiotic, P:response to gamma radiation, P:response to ischemia, P:response to salt stress, P:signal transduction by p53 class mediator, P:somitogenesis, P:stem cell proliferation, P:thymocyte apoptotic process, P:transcription initiation-coupled chromatin remodeling, P:transforming growth factor beta receptor signaling pathway, P:tumor necrosis factor-mediated signaling pathway, P:type II interferon-mediated signaling pathway, P:viral process"}
Fetching UniProt entry for gene: BRCA1
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4', 'function': "E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator", 'go_terms': 'C:BRCA1-A complex, C:BRCA1-B complex, C:BRCA1-BARD1 complex, C:BRCA1-C complex, C:DNA repair complex, C:XY body, C:chromosome, C:cytoplasm, C:gamma-tubulin ring complex, C:intracellular membraneless organelle, C:lateral element, C:male germ cell nucleus, C:nuclear body, C:nuclear ubiquitin ligase complex, C:nucleoplasm, C:nucleus, C:plasma membrane, C:protein-containing complex, C:ribonucleoprotein complex, C:ubiquitin ligase complex, F:DNA binding, F:RNA binding, F:RNA polymerase binding, F:damaged DNA binding, F:enzyme binding, F:histone H2AK127 ubiquitin ligase activity, F:histone H2AK129 ubiquitin ligase activity, F:identical protein binding, F:p53 binding, F:transcription cis-regulatory region binding, F:transcription coactivator activity, F:tubulin binding, F:ubiquitin protein ligase binding, F:ubiquitin-modified histone reader activity, F:ubiquitin-protein transferase activity, F:zinc ion binding, P:DNA damage response, P:DNA repair, P:DNA strand resection involved in replication fork processing, P:cellular response to indole-3-methanol, P:cellular response to ionizing radiation, P:cellular response to tumor necrosis factor, P:centrosome cycle, P:chordate embryonic development, P:chromatin remodeling, P:chromosome segregation, P:double-strand break repair, P:double-strand break repair via homologous recombination, P:fatty acid biosynthetic process, P:homologous recombination, P:intrinsic apoptotic signaling pathway in response to DNA damage, P:mitotic G2 DNA damage checkpoint signaling, P:mitotic G2/M transition checkpoint, P:negative regulation of DNA-templated transcription, P:negative regulation of cell cycle, P:negative regulation of cell growth, P:negative regulation of centriole replication, P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, P:negative regulation of fatty acid biosynthetic process, P:negative regulation of gene expression via chromosomal CpG island methylation, P:negative regulation of intracellular estrogen receptor signaling pathway, P:negative regulation of reactive oxygen species metabolic process, P:positive regulation of DNA repair, P:positive regulation of DNA-templated transcription, P:positive regulation of angiogenesis, P:positive regulation of gene expression, P:positive regulation of transcription by RNA polymerase II, P:positive regulation of vascular endothelial growth factor production, P:postreplication repair, P:protein K6-linked ubiquitination, P:protein autoubiquitination, P:protein ubiquitination, P:random inactivation of X chromosome, P:regulation of DNA damage checkpoint, P:regulation of DNA repair, P:regulation of cell cycle, P:regulation of transcription by RNA polymerase II, P:response to ionizing radiation, P:sex-chromosome dosage compensation'}
Fetching UniProt entry for gene: BRCA1
Extracting summaries
Extracting disease traits
Extracting function traits
Extracting GO terms
Extracted summaries: {'diseases': 'Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4', 'function': "E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator", 'go_terms': 'C:BRCA1-A complex, C:BRCA1-B complex, C:BRCA1-BARD1 complex, C:BRCA1-C complex, C:DNA repair complex, C:XY body, C:chromosome, C:cytoplasm, C:gamma-tubulin ring complex, C:intracellular membraneless organelle, C:lateral element, C:male germ cell nucleus, C:nuclear body, C:nuclear ubiquitin ligase complex, C:nucleoplasm, C:nucleus, C:plasma membrane, C:protein-containing complex, C:ribonucleoprotein complex, C:ubiquitin ligase complex, F:DNA binding, F:RNA binding, F:RNA polymerase binding, F:damaged DNA binding, F:enzyme binding, F:histone H2AK127 ubiquitin ligase activity, F:histone H2AK129 ubiquitin ligase activity, F:identical protein binding, F:p53 binding, F:transcription cis-regulatory region binding, F:transcription coactivator activity, F:tubulin binding, F:ubiquitin protein ligase binding, F:ubiquitin-modified histone reader activity, F:ubiquitin-protein transferase activity, F:zinc ion binding, P:DNA damage response, P:DNA repair, P:DNA strand resection involved in replication fork processing, P:cellular response to indole-3-methanol, P:cellular response to ionizing radiation, P:cellular response to tumor necrosis factor, P:centrosome cycle, P:chordate embryonic development, P:chromatin remodeling, P:chromosome segregation, P:double-strand break repair, P:double-strand break repair via homologous recombination, P:fatty acid biosynthetic process, P:homologous recombination, P:intrinsic apoptotic signaling pathway in response to DNA damage, P:mitotic G2 DNA damage checkpoint signaling, P:mitotic G2/M transition checkpoint, P:negative regulation of DNA-templated transcription, P:negative regulation of cell cycle, P:negative regulation of cell growth, P:negative regulation of centriole replication, P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors, P:negative regulation of fatty acid biosynthetic process, P:negative regulation of gene expression via chromosomal CpG island methylation, P:negative regulation of intracellular estrogen receptor signaling pathway, P:negative regulation of reactive oxygen species metabolic process, P:positive regulation of DNA repair, P:positive regulation of DNA-templated transcription, P:positive regulation of angiogenesis, P:positive regulation of gene expression, P:positive regulation of transcription by RNA polymerase II, P:positive regulation of vascular endothelial growth factor production, P:postreplication repair, P:protein K6-linked ubiquitination, P:protein autoubiquitination, P:protein ubiquitination, P:random inactivation of X chromosome, P:regulation of DNA damage checkpoint, P:regulation of DNA repair, P:regulation of cell cycle, P:regulation of transcription by RNA polymerase II, P:response to ionizing radiation, P:sex-chromosome dosage compensation'}
[TOOL RUN] → BioGRID
[BioGRID] Fetching predictions for gene symbol: TP53
[BioGRID] Fetching predictions for gene symbol: BRCA1
[BioGRID] Predictions fetched for 2 genes.
[BioGRID] Example predictions: [('TP53', ['SCYL2', 'nsp3', 'PLOD3', 'KRT16', 'OTUD5', 'DDX54', 'KRT35', 'CLEC4E', 'HSF1', 'RFC4', 'DIS3', 'MRPS22', 'KDR', 'TRAF7', 'PTEN', 'PDAP1', 'MYL9', 'tat', 'IDE', 'MYOT', 'RNASEH2A', 'DNAH10', 'DDX24', 'MRPS14', 'HDAC9', 'FBXO22', 'TRIP12', 'ZNF177', 'KDM4C', 'LRPAP1', 'MEX3A', 'EIF3B', 'MYBPC1', 'TET2', 'PIN1', 'KAT8', 'PARN', 'KIF20A', 'CC2D2B', 'UBR4', 'POLI', 'RAD50', 'POLR1D', 'CXXC1', 'MARS', 'SLX4IP', 'TTC16', 'WDR3', 'HIPK3', 'BCOR', 'TMEM116', 'BPTF', 'ORF8', 'EIF2S2', 'ILF3', 'KANSL3', 'RFFL', 'TRIM69', 'RBM15', 'DDX27', 'Psmd10', 'NRD1', 'CTSS', 'UFD1L', 'Melk', 'IARS2', 'MPEG1', 'EXOC3', 'GLCCI1', 'SLC25A10', 'DNAJA3', 'RCHY1', 'DDI2', 'MCL1', 'NUP93', 'Cul7', 'YBX3', 'TCERG1', 'HIF1A', 'TRAM1L1', 'LZTS2', 'FKBP3', 'KAT5', 'ZC3H15', 'LOC613037', 'PHF1', 'DSP', 'AP3B2', 'EFTUD2', 'FAM83D', 'EFNB2', 'NOL10', 'AGBL2', 'FUBP3', 'GPSM3', 'RHAG', 'KLRF1', 'PIK3C3', 'TOX4', 'STIP1']), ('BRCA1', ['PLOD3', 'DDX54', 'SLC39A10', 'RFC4', 'ACOT8', 'IFI30', 'DPY30', 'TCEA2', 'tat', 'RNASEH2A', 'EPM2AIP1', 'DDX24', 'TAF15', 'ND1', 'UBE2E2', 'UBE2J1', 'GOLGA5', 'EIF3B', 'TARDBP', 'PIN1', 'GYP5', 'PARP4', 'PSMA5', 'KIF20A', 'UBR4', 'RAD50', 'TEX101', 'MARS', 'SLX4IP', 'SYCP3', 'NCAPG2', 'BPTF', 'KIAA1804', 'ILF3', 'PA2G4', 'CTSS', 'UBR1', 'ITPR1', 'DIABLO', 'DNAJA3', 'RCHY1', 'SLI15', 'NUP93', 'HIF1A', 'Ezh2', 'KAT5', 'CDKN3', 'DSP', 'RPB4', 'EFTUD2', 'MARCKSL1', 'FHL2', 'XIAP', 'CTPS1', 'CENPU', 'POU2F1', 'FANCE', 'STIP1', 'xpo1', 'AFAP1', 'Bap1', 'PRDX1', 'CNOT1', 'TRNAU1AP', 'HERC1', 'LGALS3', 'ARIH1', 'VCL', 'ZDHHC5', 'RNPS1', 'ASF1A', 'PCNA', 'ETV6', 'PALLD', 'WBSCR16', 'USP28', 'ETV5', 'FBXO44', 'HNRNPH2', 'ANKRD32', 'SEC23IP', 'EED', 'IKBKB', 'EGFR', 'APEH', 'CCT5', 'SH2B1', 'HNRNPUL2', 'RPL5', 'TERF1', 'KIF11', 'PDS5A', 'KLHL22', 'ATR', 'EGLN3', 'CUL4B', 'TROAP', 'TUBB6', 'PGD', 'BUR2'])]
[TOOL RUN] → Summarize_bioGRID_GO
[conditioned_claude_node] preparing context block...
[conditioned_claude_node] context length: 10689
[conditioned_claude_node] context [{"gene":"TP53","gwas_associations":{"gene":"TP53","found":true,"total_associations":653,"total_significant_associations":603,"total_studies_analyzed":131,"summary_by_high_risk_alleles":{"gwas_related_genes":["TP53","TP53BP1","ATP1B2 - TP53","WRAP53","NDUFAF6","TP53I11 - LINC02685","TP53INP1","SYS1-DBNDD2","TP53TG5","NCOA6","TP53INP2","FAM228B","TP53I3","TMEM243 - TP53TG1"],"gwas_high_risk_snps":["rs28934576","rs572488097","rs545492634","rs181067279","rs78378222","rs575993546","rs201214141","rs17881850","rs1642792","rs62062585","rs2303287","rs138932666","rs190543502","rs78496430","rs150844304","rs186426979","rs17883687","rs1042522","rs55745760","rs1625895","rs74351250","rs560191","rs8073498","rs17882854","rs72829457","rs6060001","rs11762311","rs6060003","rs113910919","rs2242069","rs2909430","rs35429877","rs910870","rs2879813","rs2908806","rs34212866","rs62523081","rs4735333","rs896855","rs896854","rs4968204","rs9894946"],"gwas_affected_protein_levels":["AFP","APP","AXL","CEP43","CHL1","DAB2","DECR1","Direct low density lipoprotein levels (UKB data field 30780)","EDA2R","ERBB3","FKBP1B","FKBP1B protein level","FLT3LG","GAS6","HGFAC","NOTCH3","Non-albumin","PI3","PRDX5","PRDX5 protein level","RABGAP1L","RABGAP1L protein level","SAT2","SCRN1","SCRN1 protein level","SHBG","Serum total","TGFB1","TGFB1 protein level","TGFBI","TNFSF13","TP53","VASH1","VASH1 protein level","VAT1"],"gwas_disease_traits":["Hematocrit","Body fat percentage (adjusted for testosterone and SHBG)","AFP protein levels","Alkaline phosphatase (UKB data field 30610)","Skin cancer","Colon polyp","Eosinophil counts","Gamma glutamyl transpeptidase","HDL cholesterol","Hemoglobin","Mean corpuscular volume","Pulse pressure","Red blood cell count","Uterine fibroids","Weight","Actinic keratosis (PheCode 702.1)","Height (maximum, inv-normal transformed)","Average diameter for VLDL particles","Cholesteryl esters to total lipids ratio in IDL","Platelet distribution width"]},"summary_by_significance":{"gwas_related_genes":["TP53","TP53BP1","NDUFAF6","TP53INP1"],"gwas_high_risk_snps":["rs78378222","rs542898","rs150844304","rs2256764"],"gwas_affected_protein_levels":["High-density lipoprotein levels (MTAG)"],"gwas_disease_traits":["ICD10 D25: Leiomyoma of uterus","AFP levels","Uterine leiomyomata","Appendicular lean mass","Basal cell carcinoma (MTAG)","High-density lipoprotein levels (MTAG)","Uterine fibroids","Type 2 diabetes","Liver volume"]}},"uniprot_entries_base":{"diseases":"Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck","function":"Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2"},"uniprot_entries_gwas":{"diseases":"Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck","function":"Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2"}},{"gene":"BRCA1","gwas_associations":{"gene":"BRCA1","found":true,"total_associations":26,"total_significant_associations":24,"total_studies_analyzed":18,"summary_by_high_risk_alleles":{"gwas_related_genes":["BRCA1","NBR2"],"gwas_high_risk_snps":["rs8176279","rs567534295","rs189352191","rs535563803","rs799903","rs8176071","rs1799949","rs2236762","rs138188004","rs6503727","rs757820539","rs16942"],"gwas_affected_protein_levels":["AOC3","TMEM106A"],"gwas_disease_traits":["Aspartate aminotransferase levels","Gynecologic disease (multivariate analysis)","Ovarian cancer","Serum levels of protein STAT3","AOC3 protein levels","TMEM106A protein levels","Age at natural menopause","Menarche (age at onset)","Menopause (age at onset)","Transmembrane protein 106A levels","Telomere length (principal component 1)"]},"summary_by_significance":{"gwas_related_genes":["BRCA1","NBR2"],"gwas_high_risk_snps":["rs799903","rs757820539","rs2236762","rs199625942","rs189352191","rs8176279","rs8176255","rs1799949","rs5820482"],"gwas_affected_protein_levels":[],"gwas_disease_traits":["Age at natural menopause","Telomere length (principal component 1)","Transmembrane protein 106A levels","Neutrophil count","Serum levels of protein STAT3","Aspartate aminotransferase levels","Height","Menopause (age at onset)","Monocyte percentage of white cells","Dorsomedial frontal area"]}},"uniprot_entries_base":{"diseases":"Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4","function":"E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator"},"uniprot_entries_gwas":{"diseases":"Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4","function":"E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator"}}]
[{"gene":"TP53","gwas_associations":{"gene":"TP53","found":true,"total_associations":653,"total_significant_associations":603,"total_studies_analyzed":131,"summary_by_high_risk_alleles":{"gwas_related_genes":["TP53","TP53BP1","ATP1B2 - TP53","WRAP53","NDUFAF6","TP53I11 - LINC02685","TP53INP1","SYS1-DBNDD2","TP53TG5","NCOA6","TP53INP2","FAM228B","TP53I3","TMEM243 - TP53TG1"],"gwas_high_risk_snps":["rs28934576","rs572488097","rs545492634","rs181067279","rs78378222","rs575993546","rs201214141","rs17881850","rs1642792","rs62062585","rs2303287","rs138932666","rs190543502","rs78496430","rs150844304","rs186426979","rs17883687","rs1042522","rs55745760","rs1625895","rs74351250","rs560191","rs8073498","rs17882854","rs72829457","rs6060001","rs11762311","rs6060003","rs113910919","rs2242069","rs2909430","rs35429877","rs910870","rs2879813","rs2908806","rs34212866","rs62523081","rs4735333","rs896855","rs896854","rs4968204","rs9894946"],"gwas_affected_protein_levels":["AFP","APP","AXL","CEP43","CHL1","DAB2","DECR1","Direct low density lipoprotein levels (UKB data field 30780)","EDA2R","ERBB3","FKBP1B","FKBP1B protein level","FLT3LG","GAS6","HGFAC","NOTCH3","Non-albumin","PI3","PRDX5","PRDX5 protein level","RABGAP1L","RABGAP1L protein level","SAT2","SCRN1","SCRN1 protein level","SHBG","Serum total","TGFB1","TGFB1 protein level","TGFBI","TNFSF13","TP53","VASH1","VASH1 protein level","VAT1"],"gwas_disease_traits":["Hematocrit","Body fat percentage (adjusted for testosterone and SHBG)","AFP protein levels","Alkaline phosphatase (UKB data field 30610)","Skin cancer","Colon polyp","Eosinophil counts","Gamma glutamyl transpeptidase","HDL cholesterol","Hemoglobin","Mean corpuscular volume","Pulse pressure","Red blood cell count","Uterine fibroids","Weight","Actinic keratosis (PheCode 702.1)","Height (maximum, inv-normal transformed)","Average diameter for VLDL particles","Cholesteryl esters to total lipids ratio in IDL","Platelet distribution width"]},"summary_by_significance":{"gwas_related_genes":["TP53","TP53BP1","NDUFAF6","TP53INP1"],"gwas_high_risk_snps":["rs78378222","rs542898","rs150844304","rs2256764"],"gwas_affected_protein_levels":["High-density lipoprotein levels (MTAG)"],"gwas_disease_traits":["ICD10 D25: Leiomyoma of uterus","AFP levels","Uterine leiomyomata","Appendicular lean mass","Basal cell carcinoma (MTAG)","High-density lipoprotein levels (MTAG)","Uterine fibroids","Type 2 diabetes","Liver volume"]}},"uniprot_entries_base":{"diseases":"Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck","function":"Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2"},"uniprot_entries_gwas":{"diseases":"Adrenocortical carcinoma, Basal cell carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the head and neck","function":"Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence . Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type . Negatively regulates cell division by controlling expression of a set of genes required for this process . One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression . Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 . However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP . In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2"}},{"gene":"BRCA1","gwas_associations":{"gene":"BRCA1","found":true,"total_associations":26,"total_significant_associations":24,"total_studies_analyzed":18,"summary_by_high_risk_alleles":{"gwas_related_genes":["BRCA1","NBR2"],"gwas_high_risk_snps":["rs8176279","rs567534295","rs189352191","rs535563803","rs799903","rs8176071","rs1799949","rs2236762","rs138188004","rs6503727","rs757820539","rs16942"],"gwas_affected_protein_levels":["AOC3","TMEM106A"],"gwas_disease_traits":["Aspartate aminotransferase levels","Gynecologic disease (multivariate analysis)","Ovarian cancer","Serum levels of protein STAT3","AOC3 protein levels","TMEM106A protein levels","Age at natural menopause","Menarche (age at onset)","Menopause (age at onset)","Transmembrane protein 106A levels","Telomere length (principal component 1)"]},"summary_by_significance":{"gwas_related_genes":["BRCA1","NBR2"],"gwas_high_risk_snps":["rs799903","rs757820539","rs2236762","rs199625942","rs189352191","rs8176279","rs8176255","rs1799949","rs5820482"],"gwas_affected_protein_levels":[],"gwas_disease_traits":["Age at natural menopause","Telomere length (principal component 1)","Transmembrane protein 106A levels","Neutrophil count","Serum levels of protein STAT3","Aspartate aminotransferase levels","Height","Menopause (age at onset)","Monocyte percentage of white cells","Dorsomedial frontal area"]}},"uniprot_entries_base":{"diseases":"Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4","function":"E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator"},"uniprot_entries_gwas":{"diseases":"Breast cancer, Breast-ovarian cancer, familial, 1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic cancer 4","function":"E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage . It is unclear whether it also mediates the formation of other types of polyubiquitin chains . The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability . Regulates centrosomal microtubule nucleation . Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle . Required for FANCD2 targeting to sites of DNA damage . Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation . Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks . Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 . Acts as a transcriptional activator"}}]
[verify_evidence_node] preparing verification...
[verify_evidence_node] pass 
('{\n'
 '  "answer": "TP53 and BRCA1 are both tumor suppressor genes with distinct '
 'but complementary roles in cancer biology. TP53 functions as a '
 'multifunctional transcription factor that induces cell cycle arrest, DNA '
 'repair, or apoptosis upon DNA damage, acting as a tumor suppressor in many '
 'tumor types by negatively regulating cell division and controlling '
 'expression of genes required for this process. BRCA1 functions as an E3 '
 'ubiquitin-protein ligase that plays a central role in DNA repair by '
 'facilitating cellular responses to DNA damage, specifically contributing to '
 'homologous recombination repair and coordinating diverse cellular pathways '
 'including DNA damage repair, ubiquitination and transcriptional regulation '
 'to maintain genomic stability. Both genes are required for appropriate cell '
 'cycle arrests after DNA damage, but TP53 prevents CDK7 kinase activity in '
 'response to DNA damage while BRCA1 regulates cell cycle G2/M checkpoints '
 'through its interaction with RBBP8. TP53 is associated with a broader range '
 'of cancers including adrenocortical carcinoma, basal cell carcinoma, '
 'esophageal cancer, Li-Fraumeni syndrome, lung cancer, and squamous cell '
 'carcinoma, while BRCA1 is primarily associated with breast cancer, '
 'breast-ovarian cancer, ovarian cancer, and pancreatic cancer.",\n'
 '  "evidence": [\n'
 '    "TP53 acts as a tumor suppressor in many tumor types; induces growth '
 'arrest or apoptosis depending on the physiological circumstances and cell '
 'type",\n'
 '    "TP53 negatively regulates cell division by controlling expression of a '
 'set of genes required for this process",\n'
 '    "TP53 prevents CDK7 kinase activity when associated to CAK complex in '
 'response to DNA damage, thus stopping cell cycle progression",\n'
 '    "BRCA1 plays a central role in DNA repair by facilitating cellular '
 'responses to DNA damage",\n'
 '    "BRCA1 coordinates a diverse range of cellular pathways such as DNA '
 'damage repair, ubiquitination and transcriptional regulation to maintain '
 'genomic stability",\n'
 '    "BRCA1 contributes to homologous recombination repair (HRR) via its '
 'direct interaction with PALB2",\n'
 '    "BRCA1 required for appropriate cell cycle arrests after ionizing '
 'irradiation in both the S-phase and the G2 phase of the cell cycle",\n'
 '    "BRCA1 component of the BRCA1-RBBP8 complex which regulates CHEK1 '
 'activation and controls cell cycle G2/M checkpoints on DNA damage",\n'
 '    "TP53 diseases include Adrenocortical carcinoma, Basal cell carcinoma 7, '
 'Bone marrow failure syndrome 5, Esophageal cancer, Li-Fraumeni syndrome, '
 'Lung cancer, Papilloma of choroid plexus, Squamous cell carcinoma of the '
 'head and neck",\n'
 '    "BRCA1 diseases include Breast cancer, Breast-ovarian cancer, familial, '
 '1, Fanconi anemia, complementation group S, Ovarian cancer, Pancreatic '
 'cancer 4"\n'
 '  ]\n'
 '}')
{'answer': 'TP53 and BRCA1 are both tumor suppressor genes with distinct but '
           'complementary roles in cancer biology. TP53 functions as a '
           'multifunctional transcription factor that induces cell cycle '
           'arrest, DNA repair, or apoptosis upon DNA damage, acting as a '
           'tumor suppressor in many tumor types by negatively regulating cell '
           'division and controlling expression of genes required for this '
           'process. BRCA1 functions as an E3 ubiquitin-protein ligase that '
           'plays a central role in DNA repair by facilitating cellular '
           'responses to DNA damage, specifically contributing to homologous '
           'recombination repair and coordinating diverse cellular pathways '
           'including DNA damage repair, ubiquitination and transcriptional '
           'regulation to maintain genomic stability. Both genes are required '
           'for appropriate cell cycle arrests after DNA damage, but TP53 '
           'prevents CDK7 kinase activity in response to DNA damage while '
           'BRCA1 regulates cell cycle G2/M checkpoints through its '
           'interaction with RBBP8. TP53 is associated with a broader range of '
           'cancers including adrenocortical carcinoma, basal cell carcinoma, '
           'esophageal cancer, Li-Fraumeni syndrome, lung cancer, and squamous '
           'cell carcinoma, while BRCA1 is primarily associated with breast '
           'cancer, breast-ovarian cancer, ovarian cancer, and pancreatic '
           'cancer.',
 'evidence': ['TP53 acts as a tumor suppressor in many tumor types; induces '
              'growth arrest or apoptosis depending on the physiological '
              'circumstances and cell type',
              'TP53 negatively regulates cell division by controlling '
              'expression of a set of genes required for this process',
              'TP53 prevents CDK7 kinase activity when associated to CAK '
              'complex in response to DNA damage, thus stopping cell cycle '
              'progression',
              'BRCA1 plays a central role in DNA repair by facilitating '
              'cellular responses to DNA damage',
              'BRCA1 coordinates a diverse range of cellular pathways such as '
              'DNA damage repair, ubiquitination and transcriptional '
              'regulation to maintain genomic stability',
              'BRCA1 contributes to homologous recombination repair (HRR) via '
              'its direct interaction with PALB2',
              'BRCA1 required for appropriate cell cycle arrests after '
              'ionizing irradiation in both the S-phase and the G2 phase of '
              'the cell cycle',
              'BRCA1 component of the BRCA1-RBBP8 complex which regulates '
              'CHEK1 activation and controls cell cycle G2/M checkpoints on '
              'DNA damage',
              'TP53 diseases include Adrenocortical carcinoma, Basal cell '
              'carcinoma 7, Bone marrow failure syndrome 5, Esophageal cancer, '
              'Li-Fraumeni syndrome, Lung cancer, Papilloma of choroid plexus, '
              'Squamous cell carcinoma of the head and neck',
              'BRCA1 diseases include Breast cancer, Breast-ovarian cancer, '
              'familial, 1, Fanconi anemia, complementation group S, Ovarian '
              'cancer, Pancreatic cancer 4']}
